Skip to main content

Many Patients Unaware of Radiation Risk From CT Scans


By Genevra Pittman
NEW YORK (Reuters Health) Jan 03 - One-third of people getting a CT scan didn't know the test exposed their body to radiation, in a new study from a single U.S. medical center.
The majority of patients also underestimated the amount of radiation delivered by a CT scan, and just one in 20 believed the scan would increase their chance of ever getting cancer.
The study's lead researcher, Janet Busey, said doctors need to do a better job of talking to patients about the risks and benefits of the tests, including about radiation exposure.
One challenge is that there is still debate within the medical community about just how much long term cancer risk the scans carry, she said. That risk also depends on how many scans a patient gets and which organs are exposed to radiation.
"There's no doubt, CT saves lives," Busey, from the University of Washington in Seattle, told Reuters Health. And their benefits usually outweigh their risks, she added. Still, even if the radiation risk is small, patients "definitely should be aware of it."
In earlier studies, Busey and her colleagues learned anecdotally that many patients didn't know much about CT scans. So they surveyed 235 people who were having a non-emergency CT scan, or a single photon emission computed tomography (SPECT) scan.
Two-thirds of the patients believed their scan was definitely necessary and would benefit their health, and 84% said their doctors had explained the reason for the scan.
Two-thirds of the patients understood CT scans involve radiation, but less than half of those had learned about radiation risks from their doctor.
Few patients were worried about the scans or the link between radiation exposure and cancer. More people reported having thought about when they could eat or whether their parking would be validated after the test than about the effects of radiation, according to findings published online December 31 in JAMA Internal Medicine (formerly Archives of Internal Medicine).
"It's really a physician's job to explain to a patient what the risks and the benefits are... and sometimes we need to do a better job," said Dr. Angela Mills, an emergency medicine researcher who has studied radiation risks at the Hospital of the University of Pennsylvania in Philadelphia.
The radiation dose from one CT scan typically ranges from a couple of mSv - comparable to the yearly background radiation from natural sources - to close to 20 mSv, the annual exposure limit for nuclear industry employees.
Although each scan only has a small impact on a person's long term risk of cancer, that risk can build over time with more scans and more radiation exposure.
"To me the problem is when patients have a problem that either is chronic or they keep having pain or maybe there are alternative ways to diagnose (their condition), and patients then need to be better informed what their options are," Dr. Mills, who wasn't involved in the new study, told Reuters Health.
For example, people who develop recurring kidney stones may be able to skip a scan altogether or get an ultrasound instead of having repeat CTs, she said.
One study from the National Cancer Institute estimated there would be about 29,000 future cancers related to scans done in 2007 alone. That year, Americans had about 72 million total CT scans.
Busey said it's important to educate all patients about the benefits and possible harms of their scans - but that it will be up to the larger medical community to figure out how to do that in a way that's both standardized across facilities and individualized to each patient's particular situation.
"It's a difficult concept to understand, and risk itself is difficult to talk about," especially because of the uncertainties involved, she said.
"This is the first step."

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volum...

FDA Approves Tapentadol ER for Diabetic Neuropathy

August 29, 2012 — The US Food and Drug Administration (FDA) has approved tapentadol extended-release (ER) ( Nucynta , Janssen Pharmaceuticals, Inc) for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults for whom a continuous opioid analgesic is required over an extended time. It is the first opioid to receive this indication, the company notes in a statement today. DPN, the most common type of neuropathy, affects an estimated 16% of the more than 25 million Americans who have diabetes. The condition is often unreported and untreated, with an estimated 2 out of 5 cases not receiving care. Tapentadol ER is already approved for the treatment of moderate to severe chronic pain in adults requiring a continuous opioid analgesic for an extended period. It is a centrally acting synthetic analgesic, although the exact mechanism of action is unknown, the release states. "Although the clinical relevance is unclear," the company n...